1. Home
  2. BAK vs FTRE Comparison

BAK vs FTRE Comparison

Compare BAK & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAK
  • FTRE
  • Stock Information
  • Founded
  • BAK 1972
  • FTRE 1996
  • Country
  • BAK Brazil
  • FTRE United States
  • Employees
  • BAK N/A
  • FTRE N/A
  • Industry
  • BAK Major Chemicals
  • FTRE Medical Specialities
  • Sector
  • BAK Industrials
  • FTRE Health Care
  • Exchange
  • BAK Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • BAK 952.4M
  • FTRE 864.4M
  • IPO Year
  • BAK N/A
  • FTRE N/A
  • Fundamental
  • Price
  • BAK $2.59
  • FTRE $10.24
  • Analyst Decision
  • BAK Hold
  • FTRE Hold
  • Analyst Count
  • BAK 2
  • FTRE 9
  • Target Price
  • BAK $4.40
  • FTRE $13.06
  • AVG Volume (30 Days)
  • BAK 998.7K
  • FTRE 1.0M
  • Earning Date
  • BAK 11-10-2025
  • FTRE 11-05-2025
  • Dividend Yield
  • BAK N/A
  • FTRE N/A
  • EPS Growth
  • BAK N/A
  • FTRE N/A
  • EPS
  • BAK N/A
  • FTRE N/A
  • Revenue
  • BAK $14,266,076,929.00
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • BAK $2.44
  • FTRE N/A
  • Revenue Next Year
  • BAK $9.90
  • FTRE N/A
  • P/E Ratio
  • BAK N/A
  • FTRE N/A
  • Revenue Growth
  • BAK 10.48
  • FTRE N/A
  • 52 Week Low
  • BAK $2.32
  • FTRE $3.97
  • 52 Week High
  • BAK $6.34
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • BAK 46.39
  • FTRE 52.83
  • Support Level
  • BAK $2.58
  • FTRE $10.25
  • Resistance Level
  • BAK $2.77
  • FTRE $10.91
  • Average True Range (ATR)
  • BAK 0.10
  • FTRE 0.57
  • MACD
  • BAK 0.04
  • FTRE -0.01
  • Stochastic Oscillator
  • BAK 60.00
  • FTRE 46.96

About BAK Braskem SA ADR

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: